Addiction Medicine

Part I: History, Perspective, Epidemiology, Dx and Classification<br>1. Emerging Health Perspectives<br>2. The Epidemiology of Alcohol and Drug Disorders<br>3. United States Federal Drug Policy<br>4. Historical Perspectives of Addiction<br>5. Diagnosis and Classification of Substance Use Disorders<br>Part II: Behavioral Theories for Substance Use Disorder<br>6. Drug Reinforcement in Animals<br>7. Role of the Human Laboratory Studies in the Development of Medications for Alcohol and Substance Abuse Disorders<br>8. Conditioning of Addiction<br>9. Overlapping Striatal Circuits and Molecular Mechanisms in Rodent Models of Addiction and Depression<br>10. The Role of Endocannabinoids in Amphetamine-Driven Actions in Dopamine Neurons: Implications for Understanding and Treating Dysfunction in the Mesolimbic Circuit<br>11. Pain and Negative Affect<br>12. Genetic Vulnerability to Substance Use Disorders<br>13. Assessment and Treatment of Addiction in Best Practices and New Frontiers in a Direct to Consumer Age<br>14. Metabolomics in Drug Response and Addiction<br>Part III: Visualizations and Workings of the Addicted Brain<br>15. Visualization and Workings of the Addicted Brain<br>16. Neurobiological Basis of Drug Reward and Reinforcement<br>17. Neurobehavioral Toxicology of Substances of Abuse<br>18. Animal Models of Substance Use Disorders: Motivational Perspective<br>19. Novel Methodologies: Proteomic Approaches in Substance Abuse Research<br>20. Neuroinflammatory Processes in Drug Addiction<br>Part IV: Clinical Aspects of Alcohol and Drug Addiction<br>21. Alcohol: Clinical Aspects<br>22. Cocaine<br>23. Nicotine<br>24. Cannabis: An Overview of the Empirical Literature<br>25. Opiates and Prescription Drugs<br>26. Clinical Aspects of Methamphetamine<br>27. Sedative-Hypnotics and Anxiolytics<br>28. Clinical Aspects of Inhalant Addiction<br>29. Anabolic-Androgenic Steroids<br>30. Caffeine<br>31. Serotonergic Hallucinogens<br>32. Ketamine and Phencyclidine<br>Part V: Behavioral Addictions and Treatment<br>33. The Biology and Treatment of Pathological Gambling<br>34. Implications of "Food Addiction" for Understanding and Treating Binge Eating Disorder<br>35. Compulsive Buying<br>36. Sexual Behavior as an Addictive or Compulsive Phenomenon<br>37. New Era of Internet Addiction Research in China<br>38. Hoarding as a Behavioral Addiction<br>Part VI: Treatment and Application: Behavioral Treatments<br>39. Motivational Interviewing: Emerging Theory, Research, and Practice<br>40. Cognitive Behavioral Therapy for Addiction<br>41. Community Reinforcement Approach and Contingency Management Therapies<br>42. Relapse Prevention and Recycling in Addiction<br>43. Brief and e-Health Interventions for the Treatment of Alcohol or Other Drug Addiction <br>44. Self-Help Approaches for Addiction<br>Section VII: Treatment and Application: Group Treatments and Specific Settings<br>45. Community Clinics<br>46. Unhealthy Alcohol and Other Drug Use in Primary Care<br>47. Criminal Justice System and Addiction Treatment<br>48. Adolescent Neurocognitive Development and School-Based Drug Abuse Prevention and Treatment<br>49. The Therapeutic Community for Drug-Abuse Treatment: A Journey Yet Unfolding in the Recovery Movement<br>50. Substance Use-Focused Mutual-Help Groups: Processes and Outcomes<br>Section VIII: Treatment and Application Pharmacotherapy<br>51. Pharmacotherapy for Alcoholism and Some Related Psychiatric and Addictive Disorders: Scientific Basis and Clinical Findings<br>52. Alcohol Withdrawal: Treatment and Application<br>53. Pharmacotherapy of Cocaine Addiction<br>54. Opioid Overdose<br>55. Methamphetamine<br>56. Potential Pharmacotherapies for Cannabis Dependence<br>57. Hallucinogens<br>Section IX: Molecular Genetics, Alternative Therapies, and Other Topics in the Treatment of Addiction<br>58. Molecular Genetics and the Treatment of Addiction<br>59. Physical Considerations for Treatment Complications of Alcohol and Drug Use and Misuse<br>60. Quadruple Diagnosis: Substance Use Disorder, Comorbid Psychopathology, Human Immunodeficiency Virus Infection, and Hepatitis C Virus Infection<br>61. Substance Use Stigma as a Barrrier to Treatment and Recovery<br>62. Religiousness, Spirituality, and Addiction: An Evidence-Based Review<br>Section X: Computer Modeling<br>63. In Silico Models of Alcohol Kinetics: A Deterministic Approach<br>64. In Silico Models of Alcohol Dependence Treatment: Stochastic Approach<br>65. Dynamic and Systems-Based Models for Evaluating Hypotheses Related to Predicting Treatment Response<br>Part XI: Dependence in Specific Populations<br>66. Enhancing Positive Outcomes for Children of Substance-Abusing Parents<br>67. Alcohol and Substance Abuse in African Americans<br>68. Gays, Lesbians, and Bisexuals<br>69. Substance Use Disorders in Health Care Professionals<br>70. Identification and Treatment of Alcohol or Drug Dependence in the Elderly<br>71. Alcohol and Drugs of Abuse in Pregnant Women: Effects on Fetus and Newborn, Mode of Action, and Maternal Treatment<br>Part XII: Legal, Disability and Rehabilitative Issues<br>72. Forensic Issues<br>73. Disability and Addiction<br>74. The Homeless<br>75. To Open Up New Vistas in Basic and Preclinical Addiction Research<br>